Send the following on WhatsApp
Continue to Chat中重度斑塊型乾癬患者福音,抗 IL-23 生物製劑可克服 IL-17 治療瓶頸 https://geneonline.news/risankizumab-plaque-psoriasis-phase3-trial/?variant=zh-cn
中重度斑塊型乾癬患者福音,抗 IL-23 生物製劑可克服 IL-17 治療瓶頸 https://geneonline.news/risankizumab-plaque-psoriasis-phase3-trial/?variant=zh-cn